Benefit-risk assessment of sunitinib in gastrointestinal stromal tumours and renal cancer.
about
Residual renal function after partial or radical nephrectomy for renal cell carcinoma.The incidence and mechanism of sunitinib-induced thyroid atrophy in patients with metastatic renal cell carcinoma.Characteristics of human Ewing/PNET sarcoma models.Risk of thyroid dysfunction in patients with solid tumors treated with VEGF receptor tyrosine kinase inhibitors: a critical literature review and meta analysis.Oral adverse events associated with tyrosine kinase and mammalian target of rapamycin inhibitors in renal cell carcinoma: a structured literature review.Risk of mucocutaneous toxicities in patients with solid tumors treated with sunitinib: a critical review and meta analysis.Learning experiences with sunitinib continuous daily dosing in patients with pancreatic neuroendocrine tumoursSunitinib in advanced pancreatic neuroendocrine tumors: latest evidence and clinical potentialStructural and Functional View of Polypharmacology.Nilotinib in patients with GIST who failed imatinib and sunitinib: importance of prior surgery on drug bioavailability.
P2860
Q34179292-D74AC53E-A0E0-4D0D-9E02-D97193B28CFAQ34543752-630BF2B0-5EBC-402A-BC5C-792BAACDA727Q35008659-2494DFE5-8542-415C-BA1A-C81044A3F627Q35187896-54EB3F87-7E81-4648-82C5-C135BAED6564Q35705188-35226289-37CB-4402-83F0-C3DB98E7A54EQ38284400-FA04DB97-C57A-4ED7-A6E8-5626193CBCBEQ38285656-8F4F0C29-FD40-4E7D-BE6E-D4CF41CC4DACQ39952447-32D1E9BA-D13B-484B-92EB-FA41678BDF33Q41580357-D2FD15DD-A965-4EA9-BA06-5187C3A9CDE2Q54641441-E9BB01A6-87CB-4368-99EB-C473D051CB71
P2860
Benefit-risk assessment of sunitinib in gastrointestinal stromal tumours and renal cancer.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Benefit-risk assessment of sun ...... omal tumours and renal cancer.
@ast
Benefit-risk assessment of sun ...... omal tumours and renal cancer.
@en
type
label
Benefit-risk assessment of sun ...... omal tumours and renal cancer.
@ast
Benefit-risk assessment of sun ...... omal tumours and renal cancer.
@en
prefLabel
Benefit-risk assessment of sun ...... omal tumours and renal cancer.
@ast
Benefit-risk assessment of sun ...... omal tumours and renal cancer.
@en
P2093
P2860
P1433
P1476
Benefit-risk assessment of sun ...... omal tumours and renal cancer.
@en
P2093
Chantal Dreyer
Eric Raymond
Nathalie Theou-Anton
P2860
P304
P356
10.2165/00002018-200932090-00003
P577
2009-01-01T00:00:00Z
P6179
1046797294